Raphael Wisniewski

Filings by Raphael Wisniewski span 2 companies, the busiest being Axonics, Inc. and Tobira Therapeutics, Inc. Between 27 August 2013 and 22 January 2020, the trades on record add up to 11 filings.

Both buying and selling appear: 2 purchases worth €15.0M, against 3 sales worth €14.1M. On balance, insiders were net buyers of €904k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2020 to date brings no purchases and 2 sales.

Most recently, on 22 January 2020, the filings show an open-market sale worth €4.7M in Axonics, Inc. The most recent open-market purchase was published on 2 November 2018, 2,929 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.